Bray Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.81M | Sell |
13,662
-5,329
| -28% | -$749K | 0.49% | 57 |
|
|
2024
Q3 | $2.77M | Sell |
18,991
-178
| -0.9% | -$25.8K | 0.68% | 44 |
|
|
2024
Q2 | $2.63M | Buy |
19,169
+313
| +2% | +$41.8K | 0.66% | 44 |
|
|
2024
Q1 | $2.59M | Buy |
18,856
+180
| +1% | +$24.6K | 0.66% | 48 |
|
|
2023
Q4 | $2.54M | Sell |
18,676
-174
| -0.9% | -$21.2K | 0.7% | 44 |
|
|
2023
Q3 | $2.31M | Sell |
18,850
-660
| -3% | -$83.9K | 0.7% | 43 |
|
|
2023
Q2 | $2.48M | Sell |
19,510
-120
| -0.6% | -$15.6K | 0.74% | 42 |
|
|
2023
Q1 | $2.54M | Buy |
19,630
+53
| +0.3% | +$6.94K | 0.74% | 40 |
|
|
2022
Q4 | $2.57M | Buy |
19,577
+946
| +5% | +$122K | 0.8% | 38 |
|
|
2022
Q3 | $2.18M | Sell |
18,631
-8
| -0% | -$993 | 0.68% | 46 |
|
|
2022
Q2 | $2.19M | Buy |
18,639
+415
| +2% | +$49.3K | 0.65% | 47 |
|
|
2022
Q1 | $2.38M | Sell |
18,224
-2,346
| -11% | -$306K | 0.61% | 49 |
|
|
2021
Q4 | $3.14M | Buy |
20,570
+1,385
| +7% | +$214K | 0.77% | 44 |
|
|
2021
Q3 | $3.1M | Buy |
19,185
+12
| +0.1% | +$2.02K | 0.8% | 43 |
|
|
2021
Q2 | $3.14M | Buy |
19,173
+34
| +0.2% | +$5.24K | 0.8% | 41 |
|
|
2021
Q1 | $2.88M | Buy |
19,139
+133
| +0.7% | +$21.1K | 0.79% | 43 |
|
|
2020
Q4 | $2.88M | Sell |
19,006
-180
| -0.9% | -$25.7K | 0.84% | 40 |
|
|
2020
Q3 | $2.6M | Sell |
19,186
-25
| -0.1% | -$3.39K | 0.91% | 37 |
|
|
2020
Q2 | $2.63M | Sell |
19,211
-40
| -0.2% | -$5.1K | 1.01% | 32 |
|
|
2020
Q1 | $2.07M | Sell |
19,251
-969
| -5% | -$112K | 0.95% | 32 |
|
|
2019
Q4 | $2.44M | Buy |
20,220
+78
| +0.4% | +$8.7K | 0.87% | 40 |
|
|
2019
Q3 | $2M | Sell |
20,142
-285
| -1% | -$29.8K | 0.78% | 40 |
|
|
2019
Q2 | $2.23M | Buy |
20,427
+2,051
| +11% | +$218K | 0.86% | 40 |
|
|
2019
Q1 | $2.05M | Buy |
18,376
+393
| +2% | +$43.1K | 0.85% | 39 |
|
|
2018
Q4 | $1.73M | Sell |
17,983
-754
| -4% | -$80K | 0.87% | 33 |
|
|
2018
Q3 | $2.29M | Sell |
18,737
-315
| -2% | -$37.1K | 1.01% | 33 |
|
|
2018
Q2 | $2.09M | Sell |
19,052
-202
| -1% | -$21.6K | 0.97% | 34 |
|
|
2018
Q1 | $2.06M | Sell |
19,254
-288
| -1% | -$31.9K | 0.96% | 33 |
|
|
2017
Q4 | $2.09M | Buy |
19,542
+840
| +4% | +$89.8K | 1% | 39 |
|
|
2017
Q3 | $2.08M | Buy |
18,702
+486
| +3% | +$51.9K | 1.1% | 39 |
|
|
2017
Q2 | $1.88M | Buy |
18,216
+1,050
| +6% | +$103K | 1.03% | 43 |
|
|
2017
Q1 | $1.68M | Buy |
17,166
+2,697
| +19% | +$258K | 0.95% | 46 |
|
|
2016
Q4 | $1.28M | Sell |
14,469
-3,699
| -20% | -$337K | 0.77% | 50 |
|
|
2016
Q3 | $1.75M | Sell |
18,168
-3,003
| -14% | -$286K | 1.06% | 40 |
|
|
2016
Q2 | $1.82M | Buy |
21,171
+369
| +2% | +$33.1K | 1.13% | 38 |
|
|
2016
Q1 | $1.81M | Buy |
20,802
+939
| +5% | +$84K | 1.57% | 29 |
|
|
2015
Q4 | $2.24M | Buy |
19,863
+2,619
| +15% | +$284K | 1.42% | 24 |
|
|
2015
Q3 | $1.74M | Buy |
17,244
+1,092
| +7% | +$131K | 1.11% | 29 |
|
|
2015
Q2 | $1.99M | Hold |
16,152
| – | – | 1.14% | 22 |
|
|
2015
Q1 | $1.85M | Buy |
16,152
+4,542
| +39% | +$501K | 1.1% | 30 |
|
|
2014
Q4 | $1.17M | Buy |
+11,610
| New | +$1.13M | 0.76% | 51 |
|
Other funds holding IBB
Bray Capital Advisors's IBB Position: Q4 2024 in Review
Bray Capital Advisors reduced its iShares Biotechnology ETF (IBB) stake by 28% in Q4 2024, selling an estimated $749K and leaving 13,662 shares worth $1.81M. The position accounts for 0.49% of the portfolio, ranked #57.
Bray Capital Advisors first reported a position in IBB in Q4 2014 and has held it in 41 quarters since. The position peaked at $3.14M in Q4 2021. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.
- Bray Capital Advisors held 13,662 shares of iShares Biotechnology ETF worth $1.81M as of Q4 2024.
- Bray Capital Advisors sold 5,329 iShares Biotechnology ETF shares in Q4 2024, an estimated $749K.
- iShares Biotechnology ETF made up 0.49% of Bray Capital Advisors's portfolio in Q4 2024, its #57 holding.
- Bray Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 41 quarters since.
- Bray Capital Advisors's iShares Biotechnology ETF position peaked at $3.14M in Q4 2021.
- 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.
Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.